Informacje dodatkowe
| Use in sports | Banned by major sports organizations, used to improve endurance and performance |
|---|---|
| Formula | C815H1317N233O241S5 |
| Side effects | Hypertension, thrombosis, headache, flu-like symptoms, increased risk of stroke and myocardial infarction |
| Effects | Increases red blood cell count, improves oxygen transport and aerobic capacity |
| Dosage (sports) | Misuse doses can range from 20-50 IU/kg of body weight, administered several times a week |
| Dosage (medical) | Typically 50-300 IU/kg three times a week |
| Half-life | 4-13 hours (varies with route of administration) |
| Main action | Stimulates erythropoiesis (red blood cell production) |
| Substance class | Hematopoietic agent, Erythropoiesis-stimulating agent (ESA) |
| Chemical name | Recombinant human erythropoietin |
| Storage conditions | Store in refrigerated conditions, 2-8В°C (36-46В°F) |
| Trade name | Epogen, Procrit, Eprex |
| Blood pressure | Can cause or worsen hypertension |
| Also known as | EPO, epoetin |
| Lab Test | Erythropoietin (EPO) levels in blood can be detected via specific blood tests |
| Hepatotoxicity | None reported |
| Water Retention | Minimal to none |
| Raw Material | Human Growth Hormone |
| Manufacturer | Generic blue top |
| Packing | EPO3000iu |
|
Opinie
Na razie nie ma opinii o produkcie.